Cumberland Pharmaceuticals
CPIX
About: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Employees: 91
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
1,533% more call options, than puts
Call options by funds: $245K | Put options by funds: $15K
6.02% less ownership
Funds ownership: 30.64% [Q1] → 24.61% (-6.02%) [Q2]
6% less funds holding
Funds holding: 33 [Q1] → 31 (-2) [Q2]
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
32% less capital invested
Capital invested by funds: $18.1M [Q1] → $12.3M (-$5.81M) [Q2]
Financial journalist opinion
